Latest OssDsign News & Updates

See the latest news and media coverage for OssDsign. We track all announcements, press releases, and industry mentions in real time, all in one place.

OssDsign

Developer and provider of orthobiologics products

ossdsign.com

Headquarters: Uppsala, Sweden
Company type: Public company
Number of employees: 40–50
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about OssDsign

In short: OssDsign reported strong spinal fusion clinical results, reached 10,000 U.S. patients, and appointed Mark Waugh as its new CEO.

Company announcements

September 9 OssDsign

OssDsign announces patient enrollment in PROPEL registry

Over 400 patients enrolled in the prospective registry evaluating OssDsign Catalyst for spine fusion surgery.

June 10 OssDsign

OssDsign held its annual general meeting on 9 June 2026

Resolutions included adoption of financial statements, board elections, and approval of a long-term incentive program.

June 3 OssDsign

OssDsign Catalyst outperforms earlier bone graft in trauma study

The preclinical study shows significantly more bone formation and natural resorption of the graft over 26 weeks.

May 5 OssDsign

OssDsign publishes Q1 2026 interim report

Net sales decrease 17.1% to TSEK 36,879. Gross margin is 91.6%. EBIT is TSEK -13,466. Investor webcast held on May 5.

Media coverage

August 18 Investing.com

Earnings call transcript: OssDsign Q2 2026 sales flatten as shares fall 6% By Investing.com

OssDsign said second-quarter sales were flat from the first quarter and in line with management guidance, but the orthopedic bone graft maker continued to face...

August 3 Finanzen.net

First estimates: OssDsign Registered presents balance sheet figures for the most recent quarter.

OssDsign Registered is expected to present the figures for the most recent quarter at the quarterly financial conference on 18.08.2026. 1 analyst expects earnings per share of -0,170...

May 5 Dagens industri

Reduced turnover for Ossdsign

The medical technology company Ossdsign, with operations in implants for cranial reconstruction, reports an operating result of -13.5 million kronor for...

April 28 Dagens industri

OssDsign publishes Annual Report 2025

"A commitment to building clinical evidence remains a cornerstone of the commercialization strategy and continues to differentiate OssDsign in the market" said Mark Waugh, CEO...

Never miss news about OssDsign

Track OssDsign and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

OssDsign competitors & trending companies

Browse news for competitors to OssDsign and other trending companies.